Introduction:Basic information about CAS 241479-67-4|Isavuconazole, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Isavuconazole |
|---|
| CAS Number | 241479-67-4 | Molecular Weight | 437.46500 |
|---|
| Density | 1.38 | Boiling Point | 678ºC at 760 mmHg |
|---|
| Molecular Formula | C22H17F2N5OS | Melting Point | / |
|---|
| MSDS | / | Flash Point | 363.8ºC |
|---|
Names
| Name | isavuconazole |
|---|
| Synonym | More Synonyms |
|---|
Isavuconazole BiologicalActivity
| Description | Isavuconazole is a moderate inhibitor of CYP3A4 and a water-soluble triazole with broad-spectrum antifungal activity. |
|---|
| Related Catalog | Signaling Pathways >>Metabolic Enzyme/Protease >>Cytochrome P450Signaling Pathways >>Anti-infection >>FungalResearch Areas >>Infection |
|---|
| In Vitro | Isavuconazole shows good activity against all Candida spp., with active MIC50 of 0.004 mg/L. The MIC50s/MIC90s range from 0.002/0.004 mg/L for C. albicans to 0.25/0.5 mg/L for C. glabrata[1]. Isavuconazole has potent in vitro activity against most common Aspergillus species, Purpureocillium lilacinum, and Scedosporium apiospermum[2]. Isavuconazole shows potent activity against molds, yeasts, and dimorphic fungi. Rhizopus isolates have MIC values to isavuconazole as low as 0.12 µg/mL with others as high as 32 µg/mL[3]. In the study of pharmacokinetics and pharmacodynamics of isavuconazole against the GFP transformant, F/11628, NIH 4215, and F/16216, the modal MICs of isavuconazole are 1, 8, 1, 4 mg/L, respectively[4]. |
|---|
| References | [1]. Seifert H, et al. In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates. Antimicrob Agents Chemother. 2007 May;51(5):1818-21. [2]. Steinmann J, et al. In Vitro Activity of Isavuconazole against Rasamsonia Species. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6890-6891. [3]. Donnelley MA, et al. Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections. Infect Drug Resist. 2016 Jun 2;9:79-86. [4]. Box H, et al. Pharmacodynamics of Isavuconazole in a Dynamic In Vitro Model of Invasive Pulmonary Aspergillosis. Antimicrob Agents Chemother. 2015 Oct 26;60(1):278-87. |
|---|
Chemical & Physical Properties
| Density | 1.38 |
|---|
| Boiling Point | 678ºC at 760 mmHg |
|---|
| Molecular Formula | C22H17F2N5OS |
|---|
| Molecular Weight | 437.46500 |
|---|
| Flash Point | 363.8ºC |
|---|
| Exact Mass | 437.11200 |
|---|
| PSA | 115.86000 |
|---|
| LogP | 4.24298 |
|---|
| InChIKey | DDFOUSQFMYRUQK-RCDICMHDSA-N |
|---|
| SMILES | CC(c1nc(-c2ccc(C#N)cc2)cs1)C(O)(Cn1cncn1)c1cc(F)ccc1F |
|---|
Synonyms
| 4-{2-[(2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl}benzonitrile |
| BAL 4815 |
| UNII-60UTO373KE |
| 4-[2-[(2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl]benzonitrile |
| Isavuconazole |
| Bal4815 |
| 4-{2-[(2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)-2-butanyl]-1,3-thiazol-4-yl}benzonitrile |
| Benzonitrile, 4-[2-[(1R,2R)-2-(2,5-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]- |